48Hour Discovery (48HD) is committed to transforming the landscape of drug discovery and development with our innovative peptide-based technologies. Our robust and dynamic pipeline encompasses a diverse range of therapeutic and diagnostic radiopharmaceutical targets, reflecting our dedication to addressing critical unmet medical needs.
| Target | Hit Generation | Hit-to-Lead | Lead Optimization | Preclinical |
|---|---|---|---|---|
| PD-L1 |
|
|
|
|
| EpCAM |
|
|
||
| Undisclosed |
|
|||
| Undisclosed |
|
|||
| Undisclosed |
|
New Therapeutic Horizons
At 48Hour Discovery, we don’t just develop targets; we pioneer pathways to new therapeutic horizons. Each target in our pipeline has been meticulously selected based on its potential to impact treatment paradigms and improve patient outcomes. Our approach is driven by cutting-edge science enabling us to uncover novel peptides that could lead to breakthrough therapies.
We are constantly expanding our pipeline to include a wider array of targets, driven by advancements on our phage display platform technology. With a commitment to rigorous science and innovative techniques, we aim to rapidly advance these candidates from discovery through to clinical validation.
Our partnerships are vital to our success. We collaborate with leading academic institutions, industry experts, and healthcare professionals to ensure that our developments are not only scientifically sound but also clinically relevant and commercially viable.
Explore Collaboration Opportunities
If you are interested in exploring potential collaborations, or if you wish to learn more about specific targets in our pipeline, we encourage you to reach out. Our team is eager to discuss how we can work together to advance the field of radiopharmaceuticals and bring new solutions to the market.
Contact Us Today
Connect with us to discover how our innovative pipeline can align with your strategic goals. Whether you are looking to license a target, collaborate on research, or explore investment opportunities, we are ready to start the conversation.
